Resverlogix
0 followers
‌
Resverlogix is a biopharmaceutical company, focused on the development of therapeutics in cardiovascular diseases and Alzheimer’s disease.
Industries
+2
Headquarters
Employees
Links
Org chart
Donald J. McCaffrey
President & CEO
Donald J. McCaffrey
Collapse
Brad Cann
CFO
Ewelina Kulikowski
Chief Scientific Officer
Michael Sweeney
SVP, Clinical Development
Henrik C. Hansen
VP, Intellectual Property
